3626 (Doxycycline Hyclate 100 mg)
Pill with imprint 3626 is Orange, Round and has been identified as Doxycycline Hyclate 100 mg. It is supplied by Dava Pharmaceuticals Inc.
Doxycycline is used in the treatment of acne; actinomycosis; amebiasis; anthrax; rosacea and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 3626
Doxycycline Hyclate
- Imprint
- 3626
- Strength
- 100 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dava Pharmaceuticals Inc
- Inactive Ingredients
-
silicon dioxide,
lactose anhydrous,
hypromelloses,
magnesium stearate,
methylcellulose (400 mPa.s),
microcrystalline cellulose,
polyethylene glycol,
sodium starch glycolate type A potato,
stearic acid,
titanium dioxide,
FD&C Red No. 40,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 67253-0391 (Discontinued) | DAVA Pharmaceuticals, Inc. |
| 67405-0550 | Harris Pharmaceutical, Inc. |
| 10135-0544 | Marlex Pharmaceuticals Inc. |
| 47781-0491 | Alvogen, Inc. |
Related Images for "3626"
More about doxycycline
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,545)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: miscellaneous antimalarials
Patient resources
- Drug Information
- Doxycycline (Advanced Reading)
- Doxycycline Delayed-Release Tablets
- Doxycycline Tablets and Capsules
- Doxycycline Capsules (Rosacea)
- Other brands
- Vibramycin, Monodox, Vibra-Tabs, Oracea, ... +13 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.